Treatment-Refractory Schizophrenia: A Clinical Conundrum
Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care.

In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.

1118018030
Treatment-Refractory Schizophrenia: A Clinical Conundrum
Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care.

In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.

109.99 In Stock
Treatment-Refractory Schizophrenia: A Clinical Conundrum

Treatment-Refractory Schizophrenia: A Clinical Conundrum

Treatment-Refractory Schizophrenia: A Clinical Conundrum

Treatment-Refractory Schizophrenia: A Clinical Conundrum

Hardcover(2014)

$109.99 
  • SHIP THIS ITEM
    In stock. Ships in 1-2 days.
    Not Eligible for Free Shipping
  • PICK UP IN STORE

    Your local store may have stock of this item.

Related collections and offers


Overview

Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care.

In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.


Product Details

ISBN-13: 9783642452567
Publisher: Springer Berlin Heidelberg
Publication date: 04/01/2014
Edition description: 2014
Pages: 230
Product dimensions: 6.10(w) x 9.25(h) x 0.03(d)

Table of Contents

Definitions and scope of treatment-refractory schizophrenia.- Biology of schizophrenia: Is treatment-refractoriness synonymous with severity of illness.- Evolution of refractoriness.- Medical and psychiatric comorbidities: Complicating treatment expectations.- Overview of pharmacologic treatments and guidelines.- Clozapine: Gold standard treatment for refractory schizophrenia: Now or never.- Augmenting clozapine and other antipsychotic medications: Pharmacologic choices and differential outcomes.- Augmenting clozapine therapy: Emerging neuromodulatory strategies.- Cognitive remediation for refractory schizophrenia.- Psychological and familial therapies for refractory schizophrenia.- Vocational performance of patients with chronic schizophrenia.- Refractory schizophrenia and the criminal justice system: A failure of continuity of care and a real challenge.- Personalized medicine: A ‘game changer’ in the care of patients with treatment-refractory schizophrenia?
From the B&N Reads Blog

Customer Reviews